Interesting read

Status
Not open for further replies.
I wish I was a DR. so I could understand it....:oops:
 
No new info... but a concise presentation.
 
I wish I was a DR. so I could understand it....:oops:

Cudkowicz is interested in clinical trial design. She lists that on the Massachusetts General Hospital website.

My translation:

Since we don't have any reliable objective measure of ALS progression except death, let's keep using the shotgun approach and "measure" everything we can think of.

"Because ALS is ultimately a fatal disease, survival is an obvious choice as a marker of disease progression, as well as success or failure of experimental trials. However, as a clinical trial outcome measure, survival has a number of limitations."

Just not being dead does not mean the drug worked.
 
Status
Not open for further replies.
Back
Top